Evidence map›Paper›PMID 31146818›Full record

ArticleJournal of the American College of Cardiology2019

Modeling Cardiovascular Risks of E-Cigarettes With Human-Induced Pluripotent Stem Cell-Derived Endothelial Cells.

Won Hee Lee, Sang-Ging Ong, Yang Zhou, Lei Tian, Hye Ryeong Bae, Natalie Baker, Adam Whitlatch, Leila Mohammadi, Hongchao Guo, Kari C Nadeau and 4 more

Abstract read
In one paragraph

Article in Journal of the American College of Cardiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 87 papers.

0numbers the graph read from it
0cells of the map it votes in
87citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

87 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Human Primary Mesenchymal Stem Cells Fail to Recover Full Osteogenic Differentiation Potential Following Washout of Electronic Cigarette Aerosol Extracts.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Advancing Environmental ToxicologyEnvironment & health (Washington, D.C.) · 2024
    Review
  20. Article

27 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Won Hee LeeStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California; Department of Basic Medical Sciences, University of Arizona College of Medicine, Phoenix, Arizona. Electronic address: whlee@email.arizona.edu.
Sang-Ging OngStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California; Department of Pharmacology, University of Illinois College of Medicine, Chicago, Illinois; Division of Cardiology, Department of Medicine, University of Illinois College of Medicine, Chicago, Illinois.
Yang ZhouStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California.
Lei TianStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California.
Hye Ryeong BaeStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California.
Natalie BakerStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California.
Adam WhitlatchDepartment of Medicine, Division of Cardiology, University of California, San Francisco, California.
Leila MohammadiDepartment of Medicine, Cardiovascular Research Institute, University of California, San Francisco, California.
Hongchao GuoStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California; Department of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, California.
Kari C NadeauSean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, Stanford, California.
Matthew L SpringerDepartment of Medicine, Division of Cardiology, University of California, San Francisco, California; Department of Medicine, Cardiovascular Research Institute, University of California, San Francisco, California.
Suzaynn F SchickSchool of Medicine, Division of Occupational and Environmental Medicine, University of California, San Francisco, California.
Aruni BhatnagarDivision of Cardiovascular Medicine, University of Louisville School of Medicine, Louisville, Kentucky.
Joseph C WuStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, California; Department of Medicine, Division of Cardiology, Stanford University School of Medicine, Stanford, California. Electronic address: joewu@stanford.edu.

Funding

Training and Education p489-500P50CA180890 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GLANTZ, STANTON ARNOLD · 2013 to 2018
$20.5M
PROJECT 5: IMPACT OF CHANGING TOBACCO PRODUCT USE ON HEALTHCARE COSTS FOR GENERAL AND VULNERABLE POPULATIONSU54HL147127 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LING, PAMELA MAY · 2018 to 2022
$20.4M
Stanford Islet Research CoreP30DK116074 · NIDDK · STANFORD UNIVERSITY · PI Seung K Kim · 2017 to 2026
$19.5M
ConProject-006U54HL120163 · NHLBI · AMERICAN HEART ASSOCIATION · PI BHATNAGAR, ARUNI, ROBERTSON, ROSE MARIE · 2018 to 2022
$18.8M
Human iPSCs for Elucidating Intercellular Crosstalk Signaling in Dilated CardiomyopathyR01HL141371 · NHLBI · STANFORD UNIVERSITY · PI WONG, WING H., WU, JOSEPH C. · 2018 to 2025
$6.2M
Measuring relative cardiovascular health risks of inhaled tobacco productsR01HL120062 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SPRINGER, MATTHEW LAWRENCE · 2014 to 2018
$2.8M
CARDIAC MITOHORMESIS PROTECTS AGAINST DIABETIC CARDIOMYOPATHY THROUGH MITOPHAGY: EVALI ADMINISTRATIVE SUPPLEMENTR00HL130416 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ONG, SANG GING · 2018 to 2020
$927k
NCI NIH HHS P50 CA180890NHLBI NIH HHS R00 HL130416NHLBI NIH HHS R01 HL120062NHLBI NIH HHS R01 HL141371NHLBI NIH HHS U54 HL120163NHLBI NIH HHS U54 HL147127NIDDK NIH HHS P30 DK116074
6 · The paper itself

Abstract

backgroundElectronic cigarettes (e-cigarettes) have experienced a tremendous increase in use. Unlike cigarette smoking, the effects of e-cigarettes and their constituents on mediating vascular health remain understudied. However, given their increasing popularity, it is imperative to evaluate the health risks of e-cigarettes, including the effects of their ingredients, especially nicotine and flavorings.

objectivesThe purpose of this study was to investigate the effects of flavored e-cigarette liquids (e-liquids) and serum isolated from e-cigarette users on endothelial health and endothelial cell-dependent macrophage activation.

methodsHuman-induced pluripotent stem cell-derived endothelial cells (iPSC-ECs) and a high-throughput screening approach were used to assess endothelial integrity following exposure to 6 different e-liquids with varying nicotine concentrations and to serum from e-cigarette users.

resultsThe cytotoxicity of the e-liquids varied considerably, with the cinnamon-flavored product being most potent and leading to significantly decreased cell viability, increased reactive oxygen species (ROS) levels, caspase 3/7 activity, and low-density lipoprotein uptake, activation of oxidative stress-related pathway, and impaired tube formation and migration, confirming endothelial dysfunction. Upon exposure of ECs to e-liquid, conditioned media induced macrophage polarization into a pro-inflammatory state, eliciting the production of interleukin-1β and -6, leading to increased ROS. After exposure of human iPSC-ECs to serum of e-cigarette users, increased ROS linked to endothelial dysfunction was observed, as indicated by impaired pro-angiogenic properties. There was also an observed increase in inflammatory cytokine expression in the serum of e-cigarette users.

conclusionsAcute exposure to flavored e-liquids or e-cigarette use exacerbates endothelial dysfunction, which often precedes cardiovascular diseases.

Indexed as

Electronic Nicotine Delivery SystemsAdultCardiovascular DiseasesCase-Control StudiesCytokinesEndothelial CellsHumansInduced Pluripotent Stem CellsLeukocyte CountMacrophagesNicotineReactive Oxygen SpeciesSmokersVapingCytokinesNicotineReactive Oxygen Speciese-cigarette aerosole-liquid flavoringendothelial dysfunctioniPSC-ECs

Identifiers

PMID31146818
PMCPMC6637948

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.